DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
95 hedge funds and large institutions have $838M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 85 → 95 (+10)
Holders
95
Holding in Top 10
6
Calls
$10K
Puts
–
Top Buyers
| 1 | +$35.2M | |
| 2 | +$17.6M | |
| 3 | +$12.8M | |
| 4 |
Goldman Sachs
New York
|
+$12.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.75M |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$2.2M | |
| 3 | -$1.55M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$1.23M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.22M |